Terns Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -68.15. In total, the insiders bought 1.44M and sold 6.05M TERN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-68.15 |
| ● Buy | 1.44M shares |
| ● Sell | 6.05M shares |
|
31% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 05, 2026 Sell |
Turner Heather D Director |
1 697 Value: $58.7K |
||
|
May 05, 2026 Sell |
Tripuraneni Radhika Director |
64 000 Value: $136.3K |
||
|
May 05, 2026 Sell |
Tripuraneni Radhika Director |
45 000 Value: $184.5K |
||
|
May 05, 2026 Sell |
Tripuraneni Radhika Director |
10 657 Value: $47.5K |
||
|
May 05, 2026 Sell |
Tripuraneni Radhika Director |
4 676 Value: $32.0K |
||
|
May 05, 2026 Sell |
Tripuraneni Radhika Director |
32 000 Value: $223.7K |
||
|
May 05, 2026 Sell |
Tripuraneni Radhika Director |
32 000 Value: $385.6K |
||
|
May 05, 2026 Sell |
Quigley Jill M. Director |
32 000 Value: $385.6K |
||
|
May 05, 2026 Sell |
Quigley Jill M. Director |
1 697 Value: $58.7K |
||
|
May 05, 2026 Sell |
Kindler Jeffrey B Director |
32 000 Value: $58.2K |
||
|
May 05, 2026 Sell |
Kindler Jeffrey B Director |
45 000 Value: $184.5K |
||
|
May 05, 2026 Sell |
Kindler Jeffrey B Director |
10 657 Value: $47.5K |
||
|
May 05, 2026 Sell |
Kindler Jeffrey B Director |
4 676 Value: $32.0K |
||
|
May 05, 2026 Sell |
Kindler Jeffrey B Director |
22 000 Value: $235.8K |
||
|
May 05, 2026 Sell |
Kindler Jeffrey B Director |
32 000 Value: $385.6K |
||
|
May 05, 2026 Sell |
Fellows David A Director |
45 000 Value: $184.5K |
||
|
May 05, 2026 Sell |
Fellows David A Director |
18 650 Value: $83.2K |
||
|
May 05, 2026 Sell |
Fellows David A Director |
32 000 Value: $223.7K |
||
|
May 05, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
485 000 Value: $2.25M |
||
|
May 05, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
117 500 Value: $641.6K |
||
|
May 05, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
120 000 Value: $790.8K |
||
|
May 05, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
280 000 Value: $3.62M |
||
|
May 05, 2026 Sell |
Kuriakose Emil Chief Medical Officer |
112 500 Value: $4.18M |
||
|
May 05, 2026 Sell |
Gengos Andrew Chief Financial Officer |
40 503 Value: $2.15M |
||
|
May 05, 2026 Sell |
Burroughs Amy L. Chief Executive Officer |
8 319 Value: $440.9K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
Sign In
Buy TERN